Openwater develops wearable neurotechnology platforms based on infrared and ultrasound to enable non-invasive diagnosis and treatment of disease. The company’s approach focuses on combining advanced imaging and therapeutic modalities into compact, wearable systems. Its platforms are designed to operate without surgical intervention or large clinical infrastructure. Openwater positions its technology within experimental medical imaging and therapeutic development contexts.

The technology uses infrared light and ultrasound to image and modulate biological tissue at depth. By leveraging optical and acoustic techniques, the system aims to visualize and influence neural and vascular activity in real time. Open-source design principles are applied to both hardware and software, enabling transparency and extensibility. This approach emphasizes portability and multimodal capability rather than reliance on conventional imaging systems.

Openwater targets applications including stroke, depression, cancer, and other neurological or systemic conditions where non-invasive imaging and intervention could improve care. The platforms are intended for research, clinical development, and exploratory therapeutic use rather than consumer deployment. Its positioning reflects broader interest in wearable, non-invasive alternatives to large-scale imaging and invasive treatment technologies.